Table 1.
Novorapid® | Lantus® | Somac® | Klexane® | Marevan® | Innohep® | Furesis® | Bisoprolol® | Noradrenalin® | Zinacef® | Cefuroxim® | Kefexin® | Oxynorm® | Panadol® | Targiniq® | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novorapid® | 76 | 12 | 1 | 0 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
Lantus® | 12 | 57 | 0 | 1 | 1 | 0 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Somac® | 1 | 0 | 47 | 3 | 2 | 0 | 6 | 2 | 0 | 2 | 0 | 0 | 0 | 1 | 1 |
Klexane® | 0 | 1 | 3 | 380 | 43 | 8 | 7 | 4 | 0 | 2 | 0 | 0 | 1 | 1 | 1 |
Marevan® | 2 | 1 | 2 | 43 | 169 | 9 | 3 | 4 | 1 | 3 | 0 | 1 | 0 | 0 | 1 |
Innohep® | 0 | 0 | 0 | 8 | 9 | 91 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Furesis® | 2 | 2 | 6 | 7 | 3 | 1 | 147 | 8 | 1 | 2 | 0 | 0 | 0 | 3 | 2 |
Bisoprolol® | 0 | 1 | 2 | 4 | 4 | 0 | 8 | 64 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Noradrenalin® | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 53 | 1 | 0 | 0 | 0 | 0 | 0 |
Zinacef® | 2 | 1 | 2 | 2 | 3 | 0 | 2 | 0 | 1 | 153 | 5 | 5 | 1 | 1 | 0 |
Cefuroxim® | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 62 | 4 | 0 | 0 | 0 |
Kefexin® | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5 | 4 | 41 | 0 | 1 | 1 |
Oxynorm® | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 83 | 6 | 11 |
Panadol® | 0 | 0 | 1 | 1 | 0 | 0 | 3 | 0 | 0 | 1 | 0 | 1 | 6 | 95 | 5 |
Targiniq® | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 1 | 11 | 5 | 108 |
% distribution | 27.6% | 31.6% | 38.3% | 18.7% | 41.4% | 20.9% | 25.2% | 31.3% | 9.4% | 16.3% | 14.5% | 29.3% | 22.9% | 18.9% | 22.2% |
The overall number of reports per medication marked with bolded numbers.